Coagulation Factor IX, (recombinant), Albumin Fusion Protein (Idelvion)

OFFICE ADMINISTRATION

Indications for Prior Authorization:
  • Indicated in children and adults with Hemophilia B (congenital Factor IX deficiency) for:
    • On-demand treatment and control of bleeding episodes
    • Perioperative management of bleeding
    • Routine prophylaxis to reduce the frequency of bleeding episodes
Patients must meet the following criteria for the indications above:
  • On-demand treatment, perioperative management or routine prophylaxis for patients with Hemophilia B
  • Patient does not have a known hypersensitivity to hamster protein
Dosing:
  • One IU of Idelvion per kg body weight is expected to increase the circulating activity of Factor IX as follows:
    • Adolescents and adults: 1.3 IU/dL per IU/kg
    • Pediatrics (<12 years): 1 IU/dL per IU/kg
  • On-demand treatment and control of bleeding episdoes and perioperative management:
    • Initial dose: require dose (IU) = Body weight (kg) x desired Factor IX rise (% of normal or IU/dL) x (reciprocal of recovery (IU/kg per IU/dL))
    • Adjust dose based on the patient's clinical condition and response
  • Routine prophylaxis:
    • Patients at least 12 years of age: 25-40 IU/kg body weight every 7 days.  Patients well-controlled on this regimen may be switched to a 14-day interval at 50-75 IU/kg body weight.
    • Patients <12 years of age: 40-55 IU/kg body weight every 7 days.
Approval:
  • 1 year
Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone